Community-Acquired Pneumonia: An Unfinished Battle (Q22252366)

PubMed publication ID

22032432

7 February 2023

Michael S. Niederman

series ordinal

2

author given names

Michael S

author last names

Niederman

1 reference

PubMed publication ID

22032432

Medical Clinics of North America

7 February 2023

language of work or name

English

0 references

publication date

November 2011

0 references

published in

0 references

volume

95

0 references

issue

6

0 references

page(s)

1143-1161

0 references

cites work

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

1 reference

12 December 2020

Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia.

1 reference

12 December 2020

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis

1 reference

12 December 2020

Prognostic value of procalcitonin in community-acquired pneumonia

1 reference

12 December 2020

Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality

1 reference

12 December 2020

Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia

1 reference

12 December 2020

Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network

1 reference

12 December 2020

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

1 reference

12 December 2020

High-resolution computed tomography for the diagnosis of community-acquired pneumonia

1 reference

12 December 2020

Current and Potential Usefulness of Pneumococcal Urinary Antigen Detection in Hospitalized Patients With Community-Acquired Pneumonia to Guide Antimicrobial Therapy

1 reference

12 December 2020

Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli.

1 reference

12 December 2020

Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination

1 reference

12 December 2020

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

1 reference

12 December 2020

Inflammation in severe pneumonia: act locally, not globally

1 reference

12 December 2020

Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)

1 reference

12 December 2020

Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors

1 reference

12 December 2020

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

1 reference

12 December 2020

Management of community-acquired pneumonia: a review and update

1 reference

12 December 2020

Atypical pathogens in community-acquired pneumonia

1 reference

12 December 2020

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores

1 reference

12 December 2020

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

1 reference

12 December 2020

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

12 December 2020

Quality of care, process, and outcomes in elderly patients with pneumonia

1 reference

12 December 2020

CRB-65 predicts death from community-acquired pneumonia.

1 reference

12 December 2020

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

1 reference

12 December 2020

Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin

1 reference

12 December 2020

Predicting bacteremia in patients with community-acquired pneumonia

1 reference

12 December 2020

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

1 reference

12 December 2020

Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis

1 reference

12 December 2020

Viral community-acquired pneumonia in nonimmunocompromised adults

1 reference

12 December 2020

Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia

1 reference

12 December 2020

Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*

1 reference

12 December 2020

Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia

1 reference

12 December 2020

Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia

1 reference

12 December 2020

Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia

1 reference

12 December 2020

Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections

1 reference

12 December 2020

Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia

1 reference

12 December 2020

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

12 December 2020

Severe Community‐Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission

1 reference

12 December 2020

Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

1 reference

12 December 2020

Proton-pump inhibitor use and the risk for community-acquired pneumonia

1 reference

12 December 2020

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

1 reference

12 December 2020

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

1 reference

12 December 2020

Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

1 reference

12 December 2020

Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia

1 reference

12 December 2020

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

1 reference

12 December 2020

Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones

1 reference

12 December 2020

Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections

1 reference

12 December 2020

Genetic risk of acute pulmonary infections and sepsis

1 reference

12 December 2020

Burden of community-acquired pneumonia in North American adults

1 reference

12 December 2020

Validation of a predictive rule for the management of community-acquired pneumonia

1 reference

12 December 2020

Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'?

1 reference

12 December 2020

In the clinic. Community-acquired pneumonia

1 reference

12 December 2020

Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

1 reference

12 December 2020

Hyponatremia in community-acquired pneumonia.

1 reference

12 December 2020

Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.

1 reference

12 December 2020

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia

1 reference

12 December 2020

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

1 reference

12 December 2020

Pneumonia: still the old man's friend?

1 reference

12 December 2020